Bursary recipient will test effects of chemoradiation on patients with brain tumours

BIR president Dr Jane Phillips-Hughes, Dr Sotirios Bisdas and Siemens Healthineers regional sales manager Carl Smith.

Dr Sotirios Bisdas from University College Hospital London (UCL) has been presented with a BIR/Siemens Healthineers research bursary to test the effects of chemoradiation on the brain in a research project titled ‘Functional and structural connectivity substrates of cognition alterations in glioma patients receiving chemoradiation’.

Consultant neuroradiologist and MRI lead in the department of neuroradiology at the National Hospital for Neurology, UCL, Dr Bisdas said: “I was delighted to receive this award as a note of support and encouragement for our research in precision neuroimaging and personalised medicine in patients with brain tumours.  This seed funding grant will be used to promote our research endeavours in the field, which will shed light on the complex functional and anatomical alterations that are triggered by chemoradiation in brain tumour patients.  The results may be used to create patient-tailored treatment schemes and predict the neuropsychological outcomes after therapy.”

Read this report on page 2 of the December 2018 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more